By
Jun 02, 2026
Pharma-Track Cannabis Developer Challenges Rescheduling Order, Citing Regulatory Unfairness
A pharmaceutical cannabinoid company that spent years building a federally compliant operation - DEA-registered labs, FDA Investigational New Drug applications, Orphan Drug Designation - is now in












